John Overdeck’s IN8bio INAB Stock Holding History

John Overdeck’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-28,214	Closed	-$66K	–	4742
2025 Q4	$66K	Sell	28,214 -21,239	-43%	-$40.4K	﹤0.01%	3899
2025 Q3	$107K	Buy	+49,453	New	+$109K	﹤0.01%	3458
2024 Q2	–	Sell	-1,384	Closed	-$49K	–	3170
2024 Q1	$49K	Sell	1,384 -27	-2%	-$1.02K	﹤0.01%	2886
2023 Q4	$58.4K	Buy	+1,411	New	+$45.1K	﹤0.01%	2984
2023 Q3	–	Sell	-606	Closed	-$28K	–	3072
2023 Q2	$28K	Buy	+606	New	+$37.9K	﹤0.01%	2885

Other funds holding INAB

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

John Overdeck's INAB Position: Q1 2026 in Review

John Overdeck sold out of IN8bio (INAB) in Q1 2026, closing a stake of 28,214 shares — an estimated $66K sold.

John Overdeck first reported a position in INAB in Q2 2023 and held it in 5 quarters. The position peaked at $107K in Q3 2025. 19 funds tracked by Wall St. Rank hold INAB as of Q1 2026.

John Overdeck reported no remaining IN8bio position as of Q1 2026 after selling out during the quarter.
John Overdeck sold 28,214 IN8bio shares in Q1 2026, an estimated $66K.
John Overdeck first reported a position in IN8bio in Q2 2023 and held it in 5 quarters.
John Overdeck's IN8bio position peaked at $107K in Q3 2025.
19 funds tracked by Wall St. Rank held IN8bio as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.